about
Preclinical evidence of rapid-onset antidepressant-like effect in Radix Polygalae extractSuicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trialNewer generation antidepressants for depressive disorders in children and adolescentsSelective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescentsAssociation between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trialsSelective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety reviewComparative safety of antidepressant agents for children and adolescents regarding suicidal actsA Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorderA review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdoseRapid antidepressant effects: moving right alongA randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depressionVenlafaxine for major depressionRisk of suicide during treatment with venlafaxine, citalopram, fluoxetine, and dothiepin: retrospective cohort studyAssociation between mortality from suicide in England and antidepressant prescribing: an ecological studyPerspectives on the efficacy of antidepressants for child and adolescent depressionDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressantsThe Extrinsic Coagulation Pathway: a Biomarker for Suicidal Behavior in Major Depressive Disorder.Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled studyShould the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expressionSelective Serotonin Reuptake Inhibitors and Violent Crime: A Cohort StudyA Pharmacovigilance Approach for Post-Marketing in Japan Using the Japanese Adverse Drug Event Report (JADER) Database and Association AnalysisAssessment of the Risk of Suicide-Related Events Induced by Concomitant Use of Antidepressants in Cases of Smoking Cessation Treatment with Varenicline and Assessment of Latent Risk by the Use of VareniclineRegulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.Depression in adults: drug and physical treatments.Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials.Antidepressants and suicide in adolescents and adults: a public health experiment with unintended consequences?Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' dataExtrapyramidal side effects and suicidal ideation under fluoxetine treatment: a case reportAntidepressants and Suicide Risk: A Comprehensive OverviewKai-Xin-San series formulae alleviate depressive-like behaviors on chronic mild stressed mice via regulating neurotrophic factor system on hippocampus.Efficacy and safety of generic escitalopram versus Lexapro in the treatment of major depression: a multicenter double-blinded randomized controlled trialAcute administration of leptin produces anxiolytic-like effects: a comparison with fluoxetineChanges in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental studyAntidepressant use in suicides: a case-control study from the Friuli Venezia Giulia Region, Italy, 2005-2014.Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.Trends in depression and antidepressant prescribing in children and adolescents: a cohort study in The Health Improvement Network (THIN).Characterizing declines in pediatric antidepressant use after new risk disclosures.A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
P2860
Q21132322-000E5FD3-00FD-4FF0-A641-539BBE580061Q21245266-F313383A-A353-4FBA-A458-700EE894C4FAQ24202873-A8B6F472-0625-47AE-8E76-7FDC47AD6C17Q24244127-1FA94FED-B6CC-499C-80E6-059D1024EE1EQ24556639-9D63523D-DEC7-4B2A-82F6-CCDC8CA041DEQ24556640-42734E7D-CF59-4FF5-BB35-AC8983442A24Q24594810-AB0FD7DB-E7C7-48F7-BFC6-135821A8EDEDQ24602988-60583D5D-A873-477C-8C29-7CE71565CF46Q24606269-C14C6997-B599-47CC-9D31-A8FBFCB0EE9AQ24614410-9FB5DAC1-AE69-4276-B55E-9E11ED31EF31Q24630153-3F274608-69E6-4511-AA0B-690DA6E21DD9Q24678849-F145A8AF-0AC7-4765-B5C1-FBAB5B70487AQ24678875-A44F9011-7555-45DB-86D9-D50700C41B51Q24803753-05114626-8C6C-4D77-88D2-ED2D489F0F6CQ24812722-A1EA018A-ADD8-4E26-BF42-D0F2AE4A66E3Q26996955-9CE34B1E-6849-4BC8-8D7C-10D3B16BD35AQ27349460-FC7A3C84-BCCC-4813-AE82-75A75E9F63D2Q28254377-6F09E6C5-E2C9-4D5C-A1E3-01C978805072Q28279067-ACAA3883-1E78-49D0-B6DD-D84A177E610FQ28476686-4FFD3C41-286A-4B2C-B50A-BECA088882A3Q28548023-2EFC8C3E-FD93-4F6D-87E7-05A04DA0849BQ28551628-5296FE74-A5B4-4E3D-BBCC-D6622C22D597Q28554297-51C88803-5800-4060-9574-D694A7E06970Q30439788-D4CF4835-25D9-4046-A4DF-C9A134CCB5E7Q33303429-B96F11FD-17DC-4B5B-B3C4-F8D94A552312Q33448181-63267825-1F1A-47B5-8602-B30A9A3160B5Q33469649-53079560-0F0A-4A2A-8915-55478714FEABQ33561411-B05AC6D1-20C0-42D7-9C45-7B3057924910Q33571327-419BE49B-7294-4BF6-99F2-6C53BED2BB64Q33645300-101DDFAA-EAB9-4A0A-9CFA-0E3DC762DEEFQ33664712-71B5668E-B126-4F38-B12A-9CB3DEEDB2D5Q33684110-37826AC8-BBFA-445D-8EAE-11BE40AE0FBAQ33744405-587EE4FA-606C-426F-9093-1C89A5E75EF1Q33756416-86DD305C-B579-4B74-A5C0-815E6BF5C00AQ33774659-177057D4-9FCC-48C7-A7EC-7DC349B7ED9DQ33841870-9BE88C85-2418-4C76-9D84-D4826A1E3842Q33853140-DD5E4C30-86F7-473D-9D3E-48289E606A83Q34200603-B85F06DD-E5E3-43C0-9D17-8634D92FA415Q34283311-4B4522DA-1E3A-4C3D-94F1-B593F40E9886Q34292341-73EC8928-BD75-4865-9A39-4DAB1D1F2ABE
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antidepressants and the risk of suicidal behaviors.
@ast
Antidepressants and the risk of suicidal behaviors.
@en
Antidepressants and the risk of suicidal behaviors.
@nl
type
label
Antidepressants and the risk of suicidal behaviors.
@ast
Antidepressants and the risk of suicidal behaviors.
@en
Antidepressants and the risk of suicidal behaviors.
@nl
prefLabel
Antidepressants and the risk of suicidal behaviors.
@ast
Antidepressants and the risk of suicidal behaviors.
@en
Antidepressants and the risk of suicidal behaviors.
@nl
P921
P356
P1476
Antidepressants and the risk of suicidal behaviors.
@en
P2093
James A Kaye
P304
P356
10.1001/JAMA.292.3.338
P407
P577
2004-07-01T00:00:00Z